Psychologist, Associate Professor
Psychology
Department: Psychiatry
I am a licensed clinical psychologist and associate professor of Psychiatry and Behavioral Health at The Ohio State University Wexner Medical Center. I specialize in health psychology..
My patients can rely on me for compassionate, evidence-based care and open, respectful communication. I collaborate with a multidisciplinary team to ensure each patient receives personalized psychological support that promotes long-term wellness.
In addition to my clinical work, I am an associate professor deeply involved in research and education. I am passionate about mentoring future psychologists.
Please note: Not all physicians schedule patients at each listed location.
I am the Director of the Program for Resilience and hold The Anne K. “Nancy” Jeffrey Endowed Professorship for Mental Health Equity and Resilience. I am a neuroscientist and licensed psychologist/psychotherapist committed to clinical and translational research aimed at understanding the processes underlying risk and resilience for mental health. I study the neurobiological mechanisms that make psychotherapies effective, and I am dedicated to developing improved, accessible, neuroscience‑based treatments for stress‑related disorders such as PTSD and depression. I serve as the co‑Chair of the ENIGMA‑Meditation Working Group, an international consortium focused on meditation and mindfulness‑based intervention research. I am nationally certified in Mindfulness‑Based Cognitive Therapy (MBCT), the Cognitive Behavioral Analysis System of Psychotherapy (CBASP), and Psychedelic‑Assisted Therapy (PAT), and I am involved in clinical trials of ketamine‑ and psilocybin‑assisted therapy for psychiatric patients.
I am focused on advancing the design, testing, and implementation of effective, efficient, accessible neuroscience‑based psychotherapy interventions for psychiatric disorders, as well as empirically supported approaches for nurturing resilience and mind‑body and positive psychology interventions for people exposed to adversity and stressful life events.
I use functional MRI neuroimaging, EEG, psychophysiological, and epigenomic tools and approaches to understand the neural mechanisms within psychotherapies for PTSD and depression, including cognitive‑behavioral, mindfulness‑based, and psychedelic treatments.
I research the effects of lifespan and early life adversity on the brain, autonomic nervous system, and stress hormone and immune systems, and I have strong interest in how these effects could explain the connection between childhood adversity and substantially elevated health risks. I am a member of the Psychiatric Genomics Consortium PTSD Subcommittee and the ENIGMA‑PGC PTSD Neuroimaging Consortium. Through this work, I seek to identify ecological and modifiable social, behavioral, and cognitive‑affective factors that maximize resilience and may support improved interventions.
I am interested in understanding how mind‑body educational approaches and interventions like mindfulness, yoga, and other traditional and indigenous approaches may be useful for building resilience and buffering or ameliorating the effects of adversity in both children and adults, among our patients facing stressful conditions, and in the community.
I am author or co‑author of over 60 peer‑reviewed publications in high‑impact journals, and my research has been funded by NIMH, NCCIH, NSF, the U.S. Department of Defense, and the Mind and Life Institute.
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 11/3/2025, Dr. King has reported no relationships with companies or entities.